Yifan Pharmaceutical Co., Ltd. (SZSE:002019) signed an agreement to acquire 11.86% stake in BIOTON S.A. (WSE:BIO) from Kelipond Investment Limited for approximately CNY 270 million on August 30, 2019. In a related deal, Yifan Pharmaceutical Co., Ltd. also signed a separate agreement to acquire additional stake in BIOTON S.A. The deal value will be payable in cash. The funds will come from Yifan Pharmaceutical Co., Ltd.'s own funds or self-financed funds. The deal does not need approval from the Company's shareholders. The deal does not need any special approval or waiver from the Polish Government or from Warsaw Stock Exchange. The deal has already been approved by Yifan Pharmaceutical Co., Ltd.'s 7th Directorate in its 5th special meeting. This transaction still needs to fulfill approval, registration, or filing record procedure with the National Development and Reform Commission, Ministry of Commerce, State Administration of Foreign Exchange and relevant departments.

Yifan Pharmaceutical Co., Ltd. (SZSE:002019) completed the acquisition of 11.86% stake in BIOTON S.A. (WSE:BIO) from Kelipond Investment Limited on October 30, 2019.